Message from the new JSSHP president

Shigeru Saito, President
Japan Society for the Study of Hypertension in Pregnancy

Thank you for your interest in our society. My name is Shigeru Saito of the University of Toyama Department of Obstetrics and Gynecology, and I was recently appointed as the new president of the Japan Society for the Study of Hypertension in Pregnancy. I intend to devote myself to the role of leading this society, which has a long history.

Thus far, many veteran physicians have conducted a great deal of research related to the pathogeny, clinical state, and management of pregnant toxicosis (currently changed to the name pregnancy-induced hypertension), and its prognosis has made excellent progress. However, the prognosis for early-onset pregnancy-induced hypertension, particularly preeclampsia, is poor. In Europe and the United States, internists and obstetricians/gynecologists jointly conduct maternal care in order to overcome these problems. Until now, in Japan mainly obstetricians and gynecologists handled this because patients are pregnant women, but due to things such as an increase in late-in-life pregnancies, there has been an increase in opportunities for internal medicine and obstetrics and gynecology to cooperate for maternal care. Pregnancy-induced hypertension was also listed in the Japanese Society of Hypertension Guidelines for the Management of Hypertension 2014. I hope that our society will become a bridge between internists and obstetricians/gynecologists.

The 35th Annual Congress of JSSHP will be held at the Keio Plaza Hotel Tokyo under the chairmanship of Professor Satoru Takeda, and it will be combined with the 46th International Congress on Pathophysiology of Pregnancy (International Meeting of Organization Gestosis), chaired by Dr. Masao Nakabayashi. The congress will have outstanding physicians from other countries (21 invited guests, including Dr. Arulkumaran, the President of the International Federation of Gynecology and Obstetrics (FIGO), Dr. Brown, the President of the International Society for the Study of Hypertension in Pregnancy (ISSHP), Dr. Antsaklis, the President of the World Association of Perinatal Medicine (WAPM), and Dr. Hagberg, who is an influential figure in neonatal brain disorders), and we have also received more than 100 general speech subjects. It is rare for this many distinguished physicians from other countries to gather in Japan, and therefore I definitely hope that many physicians will participate in the congress and learn from them.

In October, an ISSHP World Congress will be held in New Orleans in the United States, and researchers on pregnancy-induced hypertension from around the world will come together there. Japan is hoping to host the 2020 ISSHP World Congress. The last time it was held in Japan was in Kobe in 1998, and therefore we would like to hold it in Japan again. For that reason, I would like as many physicians as possible to attend and make presentations at this ISSHP World Congress.

As one of our society’s projects, we are currently conducting revisions of the guideline for care and treatment of pregnancy-induced hypertension that was edited by the Japan Society for the Study of Hypertension in Pregnancy. We have already held a consensus meeting, and we are planning to summarize the guidelines this fiscal year and then issue them in the next fiscal year. I hope that they will become good guidelines (practice guidelines) that many physicians can utilize in clinical settings.

All of our members will exert their best efforts for the further development of this society. We kindly request your continued cooperation.

Copyright(C) The Japan Society for the Study of Hypertension in Pregnancy All rights reserved.